Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fotemustine and MGMT expression in metastatic melanoma
NCT00560118Phase 2Terminated
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Aug 2003
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fotemustine in melanoma, sponsored by Institut du Cancer de Montpellier. Started Aug 2003; status: terminated.
02
Drugs
fotemustine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00560118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560118.